Timcodar (VX-853) Is a Non-FKBP12 Binding Macrolide Derivative That Inhibits PPARγ and Suppresses Adipogenesis
Nutrient overload and genetic factors have led to a worldwide epidemic of obesity that is the underlying cause of diabetes, atherosclerosis, and cardiovascular disease. In this study, we used macrolide drugs such as FK506, rapamycin, and macrolide derived, timcodar (VX-853), to determine their effec...
Saved in:
| Main Authors: | Terry D. Hinds, Kezia John, Lucien McBeth, Christopher J. Trabbic, Edwin R. Sanchez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2016/6218637 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer
by: Melody Chiu, et al.
Published: (2017-01-01) -
Prostaglandins as PPARγ Modulators in Adipogenesis
by: Ko Fujimori
Published: (2012-01-01) -
Nuclear Receptor Cofactors in PPARγ-Mediated Adipogenesis and Adipocyte Energy Metabolism
by: Emily Powell, et al.
Published: (2007-01-01) -
Shared Mechanisms in Pparγ1sv and Pparγ2 Expression in 3T3-L1 Cells: Studies on Epigenetic and Positive Feedback Regulation of Pparγ during Adipogenesis
by: Yasuhiro Takenaka, et al.
Published: (2024-01-01) -
Inhibition of Protein Farnesylation Arrests Adipogenesis and Affects PPARγ Expression and Activation in Differentiating Mesenchymal Stem Cells
by: Daniel Rivas, et al.
Published: (2007-01-01)